Bahcc1^em1Ggw

CRISPR/Cas9 technology generated a TAC to GCT change resulting in a tyrosine to alanine substitution at amino acid 2537 (p.Y2537A). This is equivalent to the human mutation encoding p.Y2533A which disrupts H3K27me3 engagement. (J:334955)